INVOKANA

CANAGLIFLOZIN · Janssen Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

65 regulatory and trial events tracked for INVOKANA, covering 2012-08-17 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry